Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Citius Oncology, Inc. (CTOR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Citius Oncology, Inc. (CTOR), most recent 12 months reported: net loss $46.06M. Latest balance sheet on file: liquid cash $16.56M, total debt $3.8M, net cash $12.76M. From SEC filings. Others in Pharmaceutical Preparations: Cogent Biosciences, Inc. · Corbus Pharmaceuticals Holdings, Inc. · Corvus Pharmaceuticals, Inc. · Contineum Therapeutics, Inc. · Citius Pharmaceuticals, Inc. · Curanex Pharmaceuticals Inc · Cadrenal Therapeutics, Inc. · CYTODYN INC.

Stock screener

Watchlist